Incidence of hypertension in elderly patients intaked on internal medicine department;Prevalencia de hipertensión arterial en población mayor de 65 años ingresada en un Servicio de Medicina Interna

Anales de Medicina Interna

Volumn 23, Issue 12, 2006, Pages 577-581

  Cinza Sanjurjo, Sergio ^a,b   Cabarcos Ortiz De Barron A ^a   Nieto Pol, E ^a   Torre Carballada, J A ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b NONE   (Spain)

Author keywords

Aged; Hypertension; Internal medicine; Prevalence

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; LOOP DIURETIC AGENT;

AGE DISTRIBUTION; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; ELDERLY CARE; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTERNAL MEDICINE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RANK SUM TEST; SEX RATIO; STATISTICAL ANALYSIS; SYSTOLIC HYPERTENSION; TREATMENT PLANNING;

AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; HOSPITAL DEPARTMENTS; HUMANS; HYPERTENSION; INCIDENCE; INTERNAL MEDICINE; MALE;

EID: 34447577009     PISSN: 02127199     EISSN: 02127199     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Banegas JR, Rodríguez-Artalejo F, Ruilope LM, Graciano A, Luque M, De la Cruz-Troca JJ, et al. Hipertensión Magnitude and management in the elderly population of Spain. J Hypertens 2002; 20: 2157-64.
2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: The JNC 7 Report. JAMA 2003; 289: 2560-72.
3. Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population: data from the health examination surveys, 1960 to 1991. Hypertension 1995; 26: 60-9.
4. Kannel WB, Gordon T, Schwartz MJ. Systolic versus diastolic blood pressure and risk of coronary heart disease: Framingham Study. Am J Cardiol 1971; 27: 335-46.
5. National high blood pressure education program working group. National high blood pressure education program working group report on hypertension in the elderly. Hypertension 1994; 23: 2175-85.
6. Sagie A, Larson MG, Levy D. The natural history of borderline isolated systolic hypertension. N Eng J Med 1993; 329: 1912-7.
7. Coppela WG, Whincup PH, Walker M, Ebrahim S. Identification and management of stroke risk in older people: a national survey of current practice in primary care. J Hum Hypertens 1997; 11: 185-91.
8. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-13.
9. Banegas JR, Rodríguez-Artejo F, De la Cruz JJ, De Andrés B, Rey J. Mortalidad relacionada con la hipertensión y la presión arterial en España. Med Clin (Barc) 1999; 112: 489-94.
10. Coca A. Evolución del control de la hipertensión arterial en España. Resultados del estudio Controlpres 2001. Hipertensión 2002; 19: 390-9.
11. O'Brien E, Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G, et al, on behalf of the European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003; 21: 821-48.
12. Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years' observational study on male British doctors. BMJ 1994; 309: 901-11.
13. Wannamethee SG, Shaper AG. Patterns of alcohol intake and risk of stroke in middle-aged British men. Stroke 1996; 27: 1033-9.
14. Joint National Committee on Prevention, Detection, Evaluation, and Treatment og High Blood Pressure. The Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Presure (JNC VII). JAMA 2003; 289: 2560-72.
15. 2003 European Society of Hypertension-European Society of Cardiology. Guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011-53
16. Safar ME, Cloarec-Blauchard L, London GM. Arterial alterations in hypertension with a disproporcionate increase in systolic over diastolic blood pressure. J Hypertens 1996; 14 (Supl. 2): 103-9.
17. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 281: 2486-97.
18. Expert Committee on the diagnosis and classification of Diabetes Mellitus. American Diabetes Association: clinical practice recommendations 2002. Diabetes Care 2002; 25 (Supl. 1): S1-147.
19. Gabriel Sánchez R, Alonso Arroyo M, Bermejo Pareja F, Muñiz García J, López Rodríguez I, Suárez Fernández C, et al. Proyecto EPICARDIAN: studio epidemiológico sobre enfermedades y factores de riesgo cardiovasculares en ancianos españoles. Diseño, método y resultados preliminares. Rev Esp Geriatr Gerontol 1996; 31: 327-34.
20. ECEHA. Estudio Cooperativo Español de Hipertensión Arterial en el anciano. Primera fase-prevalencia y características de la hipertensión arterial en el anciano en España. Sociedad Española de Geriatría y Gerontología. Liga Española para la lucha contra la HTA. Sociedad Española de Cardiología. Sociedad Española de Medicina Familiar y Comunitaria. Madrid: Pharma Consult Services, SA. EDIPHARMA; 1996.
21. Rodríguez Roca GC, et al. Control de la hipertensión de los españoles > 65 años asistidos en atención primaria. Rev Esp Cardiol 2005; 58: 359-66.
22. Albaladejo Blanco C, Martín García JA, López López I, Ródenas Aguilar JL, Ingla Mas J, López Vivo J. Grupos de riesgo cardiovascular y adecuación del tratamiento farmacológico en hipertensos de edad avanzada. Hipertensión 2001; 18: 305-13.
23. Jiménez C, Magaña JE, García Y, Díaz MA, Puig EM, Álvarez MC. ¿Estamos controlando el factor de riesgo "hipertensión arterial" en la población hipertensa de nuestro centro de salud? Hipertensión 1999; 16: 332-7.
24. González-Villalpando C, Stern MP, Haffner SM, González- Villalpando ME, Gaskill S, Rivera Martínez D. Prevalence of hypertension in a mexican population according to the Sixth report of the Joint Nacional Comittee on prevention, detection, evaluation and treatment of High Blood Pressure. J Cardiovasc Risk 1999; 6: 177-81.
25. Pineda Cuenca M, Custardoy Olavarrieta J, Ortín Arróniz JM, Cano Montoso JG, Andreu Ruiz MT, Grau C. Grado de conocimiento, tratamiento y control de la hipertensión arterial, hipercolesterolemia y diabetes mellitus en la población general adulta. Aten Primaria 2004; 33: 254-60.
26. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991; 265: 3225-63.
27. López Fernández V, Peña Luengo LA, Iglesias Heredero A, Herrero Puente P, Vázquez Álvarez J, Suárez García S, et al. Prevalencia de hipertensión arterial sistólica aislada en una población mayor de 60 años. Hipertensión 2002; 19: 384-9.
28. Coca A, Ruilope LM. El bloqueo del sistema renina-angiotensina reduce la mortalidad y morbilidad cardiovascular atribuible a la hipertensión arterial en prevención primaria y secundaria. ¿El final del camino? Med Clin (Barc) 2000; 115; 78-180.
29. American Diabetes Association (ADA). Standard of medical Care for patients with Diabetes Mellitus. Diabetes Care 2002; 25 (Supl. 1): S33-49.